• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Active Filters
Displaying 399-413 of 1,170 results

1021 Exhibit: 1021 History ClinicalTrialsgov

Document IPR2022-01524, No. 1021 Exhibit - 1021 History ClinicalTrialsgov (P.T.A.B. Sep. 9, 2022)

cite Cite Document
Analyze

1007 Exhibit: 1007 Adis

Document IPR2022-01524, No. 1007 Exhibit - 1007 Adis (P.T.A.B. Sep. 9, 2022)

cite Cite Document
Analyze

1055 Exhibit: 1055 Corporate Finance Institute

Document IPR2022-01524, No. 1055 Exhibit - 1055 Corporate Finance Institute (P.T.A.B. Sep. 9, 2022)

cite Cite Document
Analyze

1016 Exhibit: 1016 2009 10 Q

Document IPR2022-01524, No. 1016 Exhibit - 1016 2009 10 Q (P.T.A.B. Sep. 9, 2022)

cite Cite Document
Analyze

1044 Exhibit: 1044 Regeneron 28 September 2008

Document IPR2022-01524, No. 1044 Exhibit - 1044 Regeneron 28 September 2008 (P.T.A.B. Sep. 9, 2022)

cite Cite Document
Analyze

1048 Exhibit: 1048 Bayer 19 August 2008

Document IPR2022-01524, No. 1048 Exhibit - 1048 Bayer 19 August 2008 (P.T.A.B. Sep. 9, 2022)

cite Cite Document
Analyze

LS0TY0Q5REENX12

Document USE OF A VEGF ANTAGONIST TO TREAT ANGIOGENIC EYE DISORDERS, 17/352,892, No. LS0TY0Q5REENX12 (U.S. Pat. App. Jan. 30, 2024)

cite Cite Document
Analyze

LP37JQ7DGREENX0

Document USE OF A VEGF ANTAGONIST TO TREAT ANGIOGENIC EYE DISORDERS, 17/352,892, No. LP37JQ7DGREENX0 (U.S. Pat. App. Nov. 17, 2023)

cite Cite Document
Analyze

LEONLYJNGREENX0

Document USE OF A VEGF ANTAGONIST TO TREAT ANGIOGENIC EYE DISORDERS, 17/352,892, No. LEONLYJNGREENX0 (U.S. Pat. App. Feb. 28, 2023)

cite Cite Document
Analyze

L6E7IH1PGREENX4

Document USE OF A VEGF ANTAGONIST TO TREAT ANGIOGENIC EYE DISORDERS, 17/352,892, No. L6E7IH1PGREENX4 (U.S. Pat. App. Aug. 3, 2022)

cite Cite Document
Analyze

LF3073V5XBLUEX5

Document USE OF A VEGF ANTAGONIST TO TREAT ANGIOGENIC EYE DISORDERS, 17/352,892, No. LF3073V5XBLUEX5 (U.S. Pat. App. Mar. 10, 2023)

cite Cite Document
Analyze

LEX88AGKXBLUEX1

Document USE OF A VEGF ANTAGONIST TO TREAT ANGIOGENIC EYE DISORDERS, 17/352,892, No. LEX88AGKXBLUEX1 (U.S. Pat. App. Mar. 7, 2023)

cite Cite Document
Analyze

LEX889UKXBLUEX4

Document USE OF A VEGF ANTAGONIST TO TREAT ANGIOGENIC EYE DISORDERS, 17/352,892, No. LEX889UKXBLUEX4 (U.S. Pat. App. Mar. 7, 2023)

cite Cite Document
Analyze

LEONLYJPGREENX0

Document USE OF A VEGF ANTAGONIST TO TREAT ANGIOGENIC EYE DISORDERS, 17/352,892, No. LEONLYJPGREENX0 (U.S. Pat. App. Feb. 28, 2023)

cite Cite Document
Analyze

LEONLYJOGREENX0

Document USE OF A VEGF ANTAGONIST TO TREAT ANGIOGENIC EYE DISORDERS, 17/352,892, No. LEONLYJOGREENX0 (U.S. Pat. App. Feb. 28, 2023)

cite Cite Document
Analyze
<< 1 2 3 4 5 ... 27 28 29 30 31 ... >>